Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'research area cell cycle rad51'

Search results for: 'research area cell cycle rad51'

Items 51-60 of 84

Page
per page
  1. Hesperadin
    A4118 Hesperadin
     1 Citation
    Target: Aurora Kinases
    Summary: Aurora B kinase inhibitor
      ≥25.85 mg/mL
  2. ETP-46464
    A8626 ETP-46464
    Target: PI3K|mTOR|DNA-PK|ATM/ATR
    Summary: ATR inhibitor,potent and selective
      ≥16.13 mg/mL
  3. SB1317
    A3794 SB1317
    Summary: CDK,JAK and FLT inhibitor
      insoluble in H2O; ≥44.87 mg/mL
  4. MLN8237 (Alisertib)
    A4110 MLN8237 (Alisertib)
     6 Citation
    Summary: Aurora A Kinase inhibitor, Potent and selective
      ≥25.95 mg/mL
  5. Barasertib (AZD1152-HQPA)
    A4112 Barasertib (AZD1152-HQPA)
     3 Citation
    Target: Aurora Kinases
    Summary: Aurora Kinase B inhibitor, Potent and selective
      ≥25.4 mg/mL
  6. CYC116
    A4125 CYC116
    Target: Aurora Kinases|FLT3|VEGFR
    Summary: Potent Aurora A/B inhibitor
      insoluble in EtOH; insoluble in H2O; ≥18.4 mg/mL
  7. Aurora A Inhibitor I
    A4126 Aurora A Inhibitor I
    Target: Aurora Kinases
    Summary: Aurora A inhibitor
      ≥29.4 mg/mL
  8. RS-1
    C3357 RS-1
    Summary: RAD51 activator
      insoluble in EtOH; insoluble in H2O; ≥20 mg/mL
  9. BS-181
    A3266 BS-181
    Target: Cyclin-Dependent Kinases
    Summary: CDK7 inhibitor,highly selective
      Soluble in DMSO
  10. RI-2
    B5881 RI-2
    Target: RAD51
    Summary: Optimized reversible RAD51 inhibitor
      ≥21.65 mg/mL

Items 51-60 of 84

Page
per page